CAS: 45798-01-4; 4-Methylpiperazine-1-Carboximidamide

该化合物是一种化学化合物,其基质是用一甲基组和一碳基甲基胺功能组替代的管子链骨和一个碳基甲基胺功能组,该结构在有机合成和制药应用中具有多功能性,特别是作为开发生物活性分子的构件.其活性碳基氨基酰胺运动能够参与凝聚和循环反应,使其对构建环流框架具有价值. 甲基基管子成分可提高药物设计中的溶性和生物利用率.该化合物由于具有潜在的再活性,通常在受控制的条件下处理,用于研究环境中探索新型治疗剂,为合成化学应用提供稳定性和再活性平衡.

结构式图片

相似化合物

77723-03-6 1208081-65-5 84727-42-4

欧盟法规

C&L通报

上下游产品

CAS号109-01-3 N-甲基哌嗪 | CAS号4023-02-3 1H-吡唑-1-甲脒盐酸盐 | CAS号867-44-7 |S|-甲基异硫脲硫酸盐 | CAS号861429-91-6 4-methylpiperaz...

合成工艺路线路线简述

    📜4-Methylpiperazine-1-Carboxamidine Hydrochloride置于sodium Ethanolate体系中,用 乙醇 作为反应溶剂,化学反应 0.5H,反应生成 4-甲基哌嗪-1-羧脒
    参考文献:ber N1-Und N2-Substituierte 2-Amino-5,6-Dihydro-4(1H)-Pyrimidinone
    标题:ber N1-Und N2-Substituierte 2-Amino-5,6-Dihydro-4(1H)-Pyrimidinone
    摘要:
    DOI:10.1007/bf00798460

    海关参考信息

    专利信息


    专利号:US-8653282-B2
    优先权日:2007-10-18
    标 题:Preparation of dihydrothieno [3,2-D] pyrimidines and intermediates used therein
    发明人:FRUTOS ROGELIO; KRISHNAMURTHY DHILEEPKUMAR; MULDER JASON ALAN; RODRIGUEZ SONIA; SENANAYAKE CHRIS HUGH; TAMPONE THOMAS G
    权利人:FRUTOS ROGELIO; KRISHNAMURTHY DHILEEPKUMAR; MULDER JASON ALAN; RODRIGUEZ SONIA; SENANAYAKE CHRIS HUGH; TAMPONE THOMAS G; BOEHRINGER INGELHEIM INT
    摘要:The invention relates to improved methods of preparing dihydrothienopyrimidines of formula 1, and intermediates thereof, (I) wherein X is SO or SO 2 , preferably SO, and wherein R A , R 1 , R 2 , R 3 , R 4 and R 5 have the meanings given in the description. The methods according to this invention are more suitable for large-scale synthesis of said compounds than prior methods because the new synthetic process avoids distillation and chromatographic purification between steps and results in a higher overall yield of the desired product.

    专利号:US-9550000-B2
    优先权日:2011-09-09
    标题 :Compositions, methods, and systems for the synthesis and use of imaging agents
    发明人:ROBINSON SIMON P; YU MING
    权利人:ROBINSON SIMON P; YU MING; LANTHEUS MEDICAL IMAGING INC
    摘要:The present invention relates to systems, compositions, and methods for the synthesis and use of imaging agents, or precursors thereof. An imaging agent precursor may be converted to an imaging agent using the methods described herein. In some cases, the imaging agent is enriched in 18 F. In some cases, an imaging agent may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs. In some embodiments, methods and compositions for assessing perfusion and innervation mismatch in a portion of a subject are provided.

    专利号:EP-3567029-A1
    优先权日:2011-09-09
    标 题:Compositions, methods, and systems for the synthesis and use of imaging agents

    专利号:US-2020397927-A1
    优先权日:2011-09-09
    标题:Compositions, methods, and systems for the synthesis and use of imaging agents

    专利号:US-2014328756-A1
    优先权日:2011-09-09
    标题:Compositions, methods, and systems for the synthesis and use of imaging agents

    专利号:JP-2018008952-A
    优先权日:2011-09-09
    标 题:Compositions, methods and systems for the synthesis and use of contrast agents

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s11426-011-4477-6
    摘要:Guo D, Liu Y, Li T, Wang N, Zhai X, Hu C, Gong P. Synthesis and antitumor activities of a new series of 4,5-dihydro-1H-thiochromeno[4,3-d]pyrimidine derivatives. Science China Chemistry. 2012 Jan 04;55(3):347–51. doi: 10.1007/s11426-011-4477-6.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知